- Home
- MERC vs NVCT Comparison
MERC vs NVCT Comparison
Compare MERC & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MERC
- NVCT
- Stock Information
- Founded
- MERC 1968
- NVCT 2020
- Country
- MERC Canada
- NVCT United States
- Employees
- MERC N/A
- NVCT N/A
- Industry
- MERC Paper
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- MERC Basic Materials
- NVCT Health Care
- Exchange
- MERC Nasdaq
- NVCT Nasdaq
- Market Cap
- MERC 190.9M
- NVCT 167.0M
- IPO Year
- MERC 1987
- NVCT 2022
- Fundamental
- Price
- MERC $1.60
- NVCT $6.06
- Analyst Decision
- MERC Hold
- NVCT Strong Buy
- Analyst Count
- MERC 3
- NVCT 3
- Target Price
- MERC $3.00
- NVCT $15.33
- AVG Volume (30 Days)
- MERC 675.0K
- NVCT 123.1K
- Earning Date
- MERC 11-06-2025
- NVCT 11-04-2025
- Dividend Yield
- MERC 13.39%
- NVCT N/A
- EPS Growth
- MERC N/A
- NVCT N/A
- EPS
- MERC N/A
- NVCT N/A
- Revenue
- MERC $1,906,971,000.00
- NVCT N/A
- Revenue This Year
- MERC N/A
- NVCT N/A
- Revenue Next Year
- MERC $13.33
- NVCT N/A
- P/E Ratio
- MERC N/A
- NVCT N/A
- Revenue Growth
- MERC N/A
- NVCT N/A
- 52 Week Low
- MERC $1.55
- NVCT $4.44
- 52 Week High
- MERC $8.28
- NVCT $11.52
- Technical
- Relative Strength Index (RSI)
- MERC 22.81
- NVCT 48.43
- Support Level
- MERC $1.55
- NVCT $5.98
- Resistance Level
- MERC $1.77
- NVCT $6.22
- Average True Range (ATR)
- MERC 0.16
- NVCT 0.36
- MACD
- MERC -0.02
- NVCT -0.01
- Stochastic Oscillator
- MERC 5.69
- NVCT 35.86
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.